Overview

A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to test the safety, tolerability and effectiveness of an investigational drug and dietary supplement to reduce the risk of vitamin D insufficiency and deficiency during the treatment of osteoporosis in men and postmenopausal women.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Alendronate
Cholecalciferol
Criteria
Inclusion Criteria:

- Men or postmenopausal women who are osteoporotic

Exclusion Criteria:

- Vitamin D deficiency

- Other disease of bone or mineral metabolism

- Digestive disease causing malabsorption

- Other significant medical conditions that are not adequately treated